BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC)

Q: What does CUSIP 07725L102 represent in this 13F holders report?

CUSIP 07725L102 is the security identifier for ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share in Q4 2016?

54 institutional investors reported ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share for Q4 2016. Use the holders table for investor-level position and value details.

CUSIP: 07725L102

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class: Equity / Ordinary Shares, par value $0.0001 per share
Shares outstanding: 1,448,978,913
Total 13F shares: 16,604,419
Share change: +6,443,412
Total reported value: $504,116,000
Price per share: $30.36
Number of holders: 54
Value change: +$195,354,542
Number of buys: 44
Number of sells: 12

Quarterly Holders Quick Answers

What is CUSIP 07725L102?
CUSIP 07725L102 identifies ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2017
Previous quarter: Q3 2016

Recent filing periods for CUSIP 07725L102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	0.23%	3,286,529	$101,258,000	—	30 Sep 2016	13F
BAKER BROS. ADVISORS LP	13F	Company	0.13%	1,912,680	$58,930,000	—	30 Sep 2016	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.08%	1,102,770	$33,976,000	—	30 Sep 2016	13F
HILLHOUSE INVESTMENT MANAGEMENT, LTD.	13F	Company	0.05%	700,000	$21,567,000	—	30 Sep 2016	13F
Boxer Capital, LLC	13F	Company	0.03%	493,630	$15,209,000	—	30 Sep 2016	13F
Temasek Holdings (Private) Ltd	13F	Company	0.03%	380,000	$11,708,000	—	30 Sep 2016	13F
BROWN ADVISORY INC	13F	Company	0.02%	351,348	$10,824,000	—	30 Sep 2016	13F
Rock Springs Capital Management LP	13F	Company	0.02%	225,000	$6,932,000	—	30 Sep 2016	13F
QVT Financial LP	13F	Company	0.01%	170,000	$5,238,000	—	30 Sep 2016	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.01%	170,000	$5,238,000	—	30 Sep 2016	13F
EcoR1 Capital, LLC	13F	Company	0.01%	163,470	$5,037,000	—	30 Sep 2016	13F
Prince Street Capital Management LLC	13F	Company	0.01%	135,400	$4,172,000	—	30 Sep 2016	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.01%	132,057	$4,069,000	—	30 Sep 2016	13F
VHCP Management II, LLC	13F	Company	0.01%	119,000	$3,666,000	—	30 Sep 2016	13F
Tekla Capital Management LLC	13F	Company	0.01%	116,707	$3,596,000	—	30 Sep 2016	13F
DAFNA Capital Management LLC	13F	Company	0.01%	90,142	$2,777,000	—	30 Sep 2016	13F
CQS Cayman LP	13F	Company	0.01%	73,358	$2,260,000	—	30 Sep 2016	13F
BAILLIE GIFFORD & CO	13F	Company	0%	68,835	$2,121,000	—	30 Sep 2016	13F
Pine River Capital Management L.P.	13F	Company	0%	61,509	$1,895,000	—	30 Sep 2016	13F
VHCP Management, LLC	13F	Company	0%	51,000	$1,571,000	—	30 Sep 2016	13F
Board of Trustees of The Leland Stanford Junior University	13F	Company	0%	50,000	$1,541,000	—	30 Sep 2016	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0%	47,307	$1,458,000	—	30 Sep 2016	13F
Ariose Capital Management Ltd	13F	Company	0%	38,599	$1,256,000	—	30 Sep 2016	13F
STATE STREET CORP	13F	Company	0%	31,852	$981,000	—	30 Sep 2016	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0%	30,900	$952,000	—	30 Sep 2016	13F
TD ASSET MANAGEMENT INC	13F	Company	0%	25,056	$772,000	—	30 Sep 2016	13F
Vident Investment Advisory, LLC	13F	Company	0%	22,751	$701,000	—	30 Sep 2016	13F
HSBC HOLDINGS PLC	13F	Company	0%	20,912	$636,000	—	30 Sep 2016	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	18,666	$575,000	—	30 Sep 2016	13F
DEUTSCHE BANK AG\	13F	Company	0%	15,390	$474,000	—	30 Sep 2016	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0%	14,758	$455,000	—	30 Sep 2016	13F
CREDIT SUISSE AG/	13F	Company	0%	12,000	$370,000	—	30 Sep 2016	13F
VIRTUS ADVISERS, LLC	13F	Company	0%	8,344	$257,000	—	30 Sep 2016	13F
MARSHALL WACE, LLP	13F	Company	0%	7,678	$237,000	—	30 Sep 2016	13F
BANK OF MONTREAL /CAN/	13F	Company	0%	6,420	$198,000	—	30 Sep 2016	13F
BlackRock Finance, Inc.	13F	Company	0%	3,652	$113,000	—	30 Sep 2016	13F
MORGAN STANLEY	13F	Company	0%	2,351	$73,000	—	30 Sep 2016	13F
UBS Group AG	13F	Company	0%	936	$29,000	—	30 Sep 2016	13F

Institutional Holders of BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC) as of Q4 2016

As of 31 Dec 2016, BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,604,419 shares. The largest 10 holders included FMR LLC, BAKER BROS. ADVISORS LP, Hillhouse Capital Management, Ltd., WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, ORBIMED ADVISORS LLC, Boxer Capital, LLC, BROWN ADVISORY INC, Temasek Holdings (Private) Ltd, and Fosun International Ltd. This page lists 54 institutional shareholders reporting positions in this security for the Q4 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders

Q4 2016 holders

Holder diff

Investor	Q3 2016 Shares	Q4 2016 Shares	Share Diff	Share Chg %	Q3 2016 Value $	Q4 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.